Clinical trials serve as fundamental research endeavours to evaluate the safety and efficacy of therapeutic interventions, including pharmaceutical drugs. One critical aspect of this process is Therapeutic Drug Monitoring (TDM), a practice that involves measuring drug concentrations in a patient's blood to optimize dosage regimens. In the context of clinical trials, TDM ensures precise drug dosing, minimizing the risk of adverse effects while maximizing therapeutic benefits. It aids researchers in understanding the pharmacokinetics and pharmacodynamics of drugs, facilitating the customization of treatment plans based on individual patient responses.
Therapeutic Drug Monitoring in clinical trials extends beyond dosage adjustments. It provides valuable data on inter-patient variability, allowing for the identification of factors influencing drug metabolism and response. This information is crucial for refining drug development strategies and designing more targeted and effective treatment approaches. The integration of TDM in clinical trials enhances the overall quality of research outcomes by offering insights into drug behavior within diverse patient populations. It plays a pivotal role in establishing evidence-based guidelines for drug administration, fostering safer and more efficacious therapeutic practices. In essence, the synergy between clinical trials and Therapeutic Drug Monitoring advances the understanding and optimization of drug therapies, ultimately benefiting patient care.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India